Modified Risk Tobacco Product Application (MRTPA)
Synchrogenix was an integral part of the first ever successful Modified Risk Tobacco Product Application (MRTPA). That submission was officially accepted for review by the FDA in July 2014. Information related to the submission is publicly available on the FDA MRTPA website.
Impact for Tobacco Industry
The US FDA’s Center for Tobacco Products (CTP) is accepting MRTPAs. The draft Guidance for Industry: Modified Risk Tobacco Product Applications, published in March 2012, represents the most current thinking publicly available on this particular topic and merely contains suggestions/recommendations. Strict requirements are yet to be enshrined.
Request a Copy of the Swedish Match MRTPA Case Study
For a complete listing of the services we offer in support of your MRTPA, please click here.
Email email@example.com for more information.